What Will Happen If We Do Nothing To Control Trachoma: Health Expectancies for Blinding Trachoma in Southern Sudan by Ngondi, Jeremiah M. et al.
What Will Happen If We Do Nothing To Control
Trachoma: Health Expectancies for Blinding Trachoma in
Southern Sudan
Jeremiah M. Ngondi
1,2*, Fiona E. Matthews
3, Mark H. Reacher
1,4, Jonathan King
2, Carol Brayne
1, Hebe
Gouda
1, Paul M. Emerson
2
1Department of Public Health and Primary Care, Institute of Public Health, University of Cambridge, Cambridge, United Kingdom, 2The Carter Center, Atlanta, Georgia,
United States of America, 3MRC Biostatistics Unit, Institute of Public Health, Cambridge, United Kingdom, 4Health Protection Agency, East of England Regional
Epidemiology Unit, Institute of Public Health, Cambridge, United Kingdom
Abstract
Background: Uncontrolled trachoma is a leading cause of blindness. Current global trachoma burden summary measures
are presented as disability adjusted life years but have limitations due to inconsistent methods and inadequate population-
based data on trachomatous low vision and blindness. We aimed to describe more completely the burden of blinding
trachoma in Southern Sudan using health expectancies.
Methodology/Principal Findings: Age and gender specific trachomatous trichiasis (TT) prevalence was estimated from 11
districts in Southern Sudan. The distribution of visual acuity (VA) in persons with TT was recorded in one district. Sudan life
tables, TT prevalence, and VA were used to calculate Trichiasis Free Life Expectancy (TTFLE) and Trichiasis Life Expectancy
(TTLE) using the Sullivan method. TTLE was broken down by VA to derive TTLE with normal vision, TTLE with low vision, and
TTLE with blindness. Total life expectancy at birth in 2001 was 54.2 years for males and 58.1 for females. From our Sullivan
models, trichiasis life expectancy at the age of 5 years was estimated to be 7.0 (95% confidence interval [CI]=6.2–7.8) years
(12% [95% CI=11–14] of remaining life) for males and 10.9 (95% CI=9.9–11.9 ) years (18% [95% CI=16–20] of remaining
life) for females. Trichiasis life expectancy with low vision or blindness was 5.1 (95% CI=3.9–6.4) years (9% [95% CI=7–11] of
remaining life) and 7.6 (95% CI=6.0–9.1) years (12% [95% CI=10–15] of remaining life) for males and females, respectively.
Women were predicted to live longer and spend a greater proportion of their lives with disabling trichiasis, low vision, and
blindness compared to men.
Conclusions: The study shows the future burden associated with doing nothing to control trachoma in Southern Sudan,
that is, a substantial proportion of remaining life expectancy spent with trichiasis and low vision or blindness for both men
and women, with a disproportionate burden falling on women.
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Introduction
Trachoma is one of the oldest infectious diseases known to
mankindand istheleadinginfectiouscause ofblindness,estimatedto
be responsible for 2.9% of blindness worldwide [1]. Recurrent
infection with ocular Chlamydia trachomatis results in chronic
inflammation, scarring, trichiasis, corneal opacification, and blind-
ness [2–4]. Blindness due to trachoma is preventable through the
World Health Organization (WHO) SAFE strategy which compris-
es: Surgery, eyelid surgery to correct in-turned eyelashes which stops
pain and minimizes risk of corneal damage; Antibiotic treatment for
active trachoma using single-dose oral azithromycin or topical
tetracycline; Facial cleanliness, promotion of clean faces especially in
children through sustained behaviour change; and Environmental
improvements to increase access to water and sanitation [5].
Summary measures of population health, including disability
adjusted life years (DALYs) [6] and handicap adjusted life years
(HALYs) [7], have been used to estimate the global burden
attributable to trachoma. DALYs and HALYs are population
health measures permitting morbidity and mortality to be
simultaneously described within a single number and estimate
the gap between a population’s health and some defined goal. The
methodology and data sources describing trachoma DALYs and
HALYs have differed such that direct comparisons are not
possible. For instance, Evans and Ranson estimated global burden
of trachoma for the year 1990 to be 80.0 million HALYs [7]; while
for the same years the Global Burden of Disease (GBD 1990)
project reported trachoma burden to be 1.0 million DALYs [8].
Additionally, studies describing the global burden of trachoma for
the year 2000 yielded different estimates of 2.2 million DALYs [6]
www.plosntds.org 1 March 2009 | Volume 3 | Issue 3 | e396and 3.6 million DALYs [9]. These previous estimates also have
limitations arising from paucity of population-based data on
trachomatous low vision and blindness [7,9,10].
We aimed to demonstrate the application of the health
expectancies approach for trachomatous trichiasis health states
(any trichiasis, trichiasis with normal vision, trichiasis with low
vision, and trichiasis with blindness) as a summary measure of
trachoma burden using population-based survey data from
Southern Sudan. Health expectancy is a measure that combines
information on both mortality and morbidity to derive lengths of
time spent in different states of health. The methods presented can
be applied to other trachoma endemic areas and presents
estimates of the potential burden of blinding trachoma if control
measures are not implemented.
Methods
Ethics Statement
The Institutional Review Board of Emory University approved
the survey protocols and clearance to conduct surveys was obtained
from the Sudan Peoples Liberation Movement Secretariat of Health
(SPLM/Health). Verbal informed consent to participate was sought
from the heads of the household, from each individual and the
parents of children aged less than 10 years in accordance with the
declaration of Helsinki. Consent for household interviews and eye
examination was documented by interviewers and examiners on the
data collection forms. Personal identifiers were removed from the
data set before analyses were undertaken.
Cross-Sectional Surveys
Surveys for trachoma were conducted in eleven districts in
Southern Sudan between 2001 and 2006 [11–13]. For each district,
the sample size was calculated to allow for estimation of at least 50%
prevalence of active trachoma signs in children aged 1–9 years
within a precision of 10% given a 95% confidence limit and a design
effect of 5. We also aimed to estimate at least 2.5% prevalence of
trachomatrichiasis (TT)inpersons aged 15 yearsand abovewithin a
precision of 1.5% at 95% confidence limit and a design effect of 2.
The districts were selected on the basis of pragmatic program
implementation criteria of: 1) anecdotal reports of blinding
trachoma; 2) security and accessibility; and 3) feasibility of initiating
trachoma control interventions after the survey.
A two-stage cluster random sampling with probability propor-
tional to size was used to select the sample population in each
district. A cluster was defined as the population within a single
village. Using a line listing of all the villages in each survey district,
villages were grouped into sub-districts. Villages that were
inaccessible and/or insecure were excluded from the sampling
frame. In the first stage, villages were randomly selected with
probability proportional to the estimated population of the sub-
district. In the second stage, households were selected from the
villages selected in the previous stage using the random-walk
method [14], except in Ayod district where the compact segment
method [15] was used for sampling households. All residents of
selected households were enumerated and those present were
eligible for eye examination. It was not possible to return later to
the households to pick up any absentees and households where
residents were not available were skipped.
Trachoma Examination
Trainee examiners comprising of auxiliary nurses and commu-
nity health workers were trained using the WHO simplified
grading system [16] by a senior examiner experienced in
trachoma grading (ophthalmologist or ophthalmic nurse). The
minimum accepted inter-observer agreement was set at 80% and
reliability assessed in two stages. In the first stage, trainee
examiners identified trachoma grades using the WHO sets of
trachoma slides [17,18]. Those examiners who achieved at least
80% agreement then proceeded to the second stage of field
evaluation. During field evaluation a reliability study comprising
50 persons of varying age and gender were selected by the
ophthalmic nurse to represent all trachoma grades. Each trainee
examiner evaluated all 50 subjects independently and recorded
their findings on a pre-printed form. Inter-observer agreement
was then calculated for each trainee using the senior examiners’
observation as the ‘gold standard’. Only trainees achieving at
least 80% inter-observer agreement after the field evaluation were
included as trachoma graders.
All persons living within each selected household who gave
verbal consent were examined using a torch and a 62.5
magnifying binocular loupe in accordance to the simplified
grading system. Alcohol-soaked cotton-swabs were used to clean
the examiner’s fingers between examinations. All examined
participants were assigned a dichotomous outcome for each
trachoma sign based on the worst affected eye. TT was defined by
the presence of at least one eye lash touching the eyeball or
evidence of epilation of the eyelashes. Individuals with signs of
active trachoma were offered treatment with 1% tetracycline eye
ointment. Patients TT were referred to the health centre where
free eyelid surgery was available.
Visual Acuity Testing
In one district (Mankien), visual acuity (VA) testing was
conducted in all eligible participants [19]. Experienced Integrated
eye care workers (IECW) were re-trained in VA testing, basic eye
examination and trachoma grading and their reliability assessed.
Only trainees achieving an inter-observer agreement of 80% and
above were eligible to participate as examiners. Prior to the survey,
the minimum age for visual acuity (VA) testing was predetermined
to be 5 years. VA testing was conducted outdoors in adequate
sunlight using the Snellen E chart at 6 meters. In persons with
VA,6/60, VA was evaluated with the Snellen chart at 3 meters.
Further VA assessment was done in persons with VA,3/60 by
Author Summary
Summary measures of population health attempt to
express disease burden in terms of a common ‘‘currency’’
and are useful in establishing public health priorities.
Disability adjusted life years (DALYs), a health gap
measure, have previously been used to estimate burden
due to trachoma; however, their methods and results have
limitations. This study demonstrates the application of the
health expectancies to estimate burden due to trachoma.
The study illustrates the future burden associated with
doing nothing to control trachoma in Southern Sudan: a
substantial proportion of remaining life expectancy spent
with trichiasis and low vision or blindness for both men
and women, with a disproportionate burden falling on
women. The results presented are intuitively meaningful
for policy makers and a non-technical audience and
compare favourably with other indicators such as mortality
and incidence rates or DALYs, which are not generally
easily understood. Unless action is taken by further
delivery of trachoma control interventions, then popula-
tions in Southern Sudan can expect to spend a substantial
proportion of their life with low vision or blindness due to
trachoma.
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appropriate. All participants then underwent basic eye examina-
tion. Using a torch and a 62.5 magnifying binocular loupe, each
eye was examined first for in-turned lashes (TT), and the cornea
was then inspected for corneal opacities (CO), and the lens
examined for cataract. Persons with visual impairment were
referred to attend an eye surgery-camp conducted after the survey.
Data were recorded on a customized form and the cause of
visual impairment determined for all subjects with a presenting
VA of ,6/18 for each eye separately. The principal disorder
responsible for low vision or blindness was determined for the
participant by taking into account the main cause for each
individual eye. Vision loss was attributed to trachoma in persons
presenting with trichiasis and corneal opacity. In the instance
where different causes of vision loss had been identified for each
eye separately in a given individual, the principal disorder was
chosen to be the one that was most readily curable or, if not
curable, most easily preventable (i.e. cataract, trachoma, non-
trachomatous CO, and other causes in that order). To define the
vision status we adopted the WHO categories of visual impairment
based on presenting visual acuity (Box 1).
Distribution of Vision Status
Our model of the distribution of vision status has been described
previously [19]. In brief; using VA data for persons presenting with
TT from Mankien survey, age specific distributions of vision status
were calculated for 5-year age intervals. We then fitted an ordinal
logistic regression model to the observed data to explore the age
and gender distribution of the three categories of vision status:
normal vision; low vision; and blindness. Persons with visual
impairment not directly attributable to trichiasis were excluded
from the final model. Children aged 0–4 years were assumed to
have normal vision. Predicted probabilities were derived to smooth
age-specific curves for the three categories of vision status.
Life Tables for Sudan
Life tables are frequently used in demography, actuarial science
and health services. They trace the life expectancy in pre-
determined intervals for a hypothetical population size (frequently
100,000 births) based on parameters usually derived from vital
registration data. Abridged life tables for Sudan for the year 2001
were obtained from the World Health Organisation Statistical
Information System (WHOSIS) for males and females separately
[20]. Demographic estimates for Sudan are based on model life
tables because vital registration data are poor or not available. The
life tables were derived using the Modified Logit model life table
system which is extensively used for countries with poor vital
registration. The Modified Logit system has been modelled using
data from other populations judged to be similar and is indexed on
the number of survivors at age five years and the number of
survivors at age 60 years [21].
Definition of Health States
The health states used to describe the burden due to trachoma
were defined as follows: Total Life Expectancy, the total lifespan at
birth (years); Trichiasis Free Life Expectancy (TTFLE), the
expectation of life without any trichiasis; and Trichiasis Life
Expectancy (TTLE), the expectation of life with any trichiasis.
TTLE was then broken down into three health states: 1) TTLE
with normal vision, the expectation of life with any trichiasis and
normal vision (presenting VA$6/18 in better eye); 2) TTLE with
low vision, the expectation of life with any trichiasis and low vision
(presenting VA,6/18 but $3/60 in better eye); and 3) TTLE
with blindness, the expectation of life with any trichiasis and
blindness (presenting VA,3/60 in the better eye).
Statistical Analysis
The data analysis framework issummarised inFigure 1.Microsoft
Excel spreadsheets developed by the European Health Expectancy
Monitoring Unit were adapted for the calculation of health
expectancies [22]. Age and gender specific prevalence of trichiasis
was estimated from cross-sectional surveys and modelled using
logistic regression to smooth the prevalence estimates. The
distribution of vision status was derived from Mankien survey
whereby visual acuity was categorized into normal vision, low vision
and blindness; and modelled by ordinal logistic regression to provide
proportions for each category of VA by age and gender [19]. The
prevalence of vision status in the sample population was then
calculated by multiplying the age and gender specific proportions of
vision status with the smoothed prevalence of trichiasis. Life tables
werecollapsed torepresent5-yearage-groupsfrom agezero(0) to75
years and above. Trichiasis Free Life Expectancy (TTFLE) and
Trichiasis Life Expectancy (TTLE) were then calculated using the
Sullivan method [23]. The Sullivan method combines use of life
tables and age specific prevalence of morbidity to partition life
expectancy into years with and without morbidity. The Sullivan
health expectancy reflects the current health of the population
adjusted for mortality levels and independent of age structure.
Health expectancy calculated by the Sullivan method is the number
of remaining years, at a particular age, that an individual can expect
Figure 1. Summary of data framework for analysis of trichiasis
health expectancies. TT, trachomatous trichiasis; WHOSIS, World
Health Organization Statistical Information System.
doi:10.1371/journal.pntd.0000396.g001
Box 1. Definitions of vision status based on presenting
visual acuity: adopted from international statistical classi-
fication of diseases and related health problems (ICD-10;
Block H53-H54) [34]
N Blindness: presenting visual acuity of less than 3/60 in the
better eye
N Low vision: presenting visual acuity of less than 6/18 but
equal to or better than 3/60 in the better eye
N Normal vision: presenting visual acuity of better than or
equal to 6/18 in the better eye
N Visual impairment: refers to presence of either low vision
or blindness
Health Expectancies for Blinding Trachoma
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further broken down by vision status to derive TTLE with normal
vision, TTLE with low vision and TTLE with blindness
Results
The Study Population, Prevalence of Trichiasis, and
Trichiasis Vision Status
Table 1 summarises the study population. A total of 23,139
(87.2% of those enumerated) people, in 11 districts, were
examined for trachoma of whom males comprised 43%. The
overall prevalence of trachomatous trichiasis (all ages) was
6.0% (95% confidence interval [CI]=5.2–7.0) and varied
by district ranging from 0.7% in Katigiri to 10.0% in
Kimotong. Of 341 people with TT in Mankien district, 319
were included in modelling of the distribution of vision status
(i.e. TT with normal vision, TT with low vision and TT with
blindness). The distribution of proportions of vision status by
age and gender in persons with trichiasis is shown in Table 2
[19].
Table 1. The study population and distribution of vision status.
District Survey Year Sample Population Trachomatous Trichiasis
People
Enumerated
People
Examined
Response Rate
(%)
People Examined
%M a l e s
Number of
Cases Prevalence % (95%CI)
Paluer 2002 3,650 2,999 82.2 39.9 162 5.4 (4.2–6.9)
Padak 2002 2,277 1,822 80.0 46.8 87 4.8 (3.0–7.5)
Kongor 2004 2,475 1,927 77.9 45.3 52 2.7 (1.6–4.7)
Boma 2003 2,576 2,391 92.8 45.5 174 7.3 (3.6–14.1)
Kiechkuon 2002 1,738 1,530 88.0 37.9 125 8.2 (6.5–10.3)
Mankien 2005 3,976 3,567 89.7 44.5 341 9.6 (70–13.0)
Katigiri 2001 1,743 1,642 94.2 43.5 12 0.7 (0.2–2.3)
Tali 2001 1,530 1,433 93.7 42.6 32 2.2 (1.3–3.4)
Narus 2004 2,049 1,681 82.0 35.1 51 3.0 (2.1–4.3)
Kimotong 2004 1,735 1,586 91.4 40.1 159 10.0 (5.1–18.8)
Ayod 2006 2,605 2,561 98.3 48.0 182 7.1 (5.8–10.8)
Total 26,354 23,139 87.8 43.0 1,377 6.0 (5.2–7.0)
doi:10.1371/journal.pntd.0000396.t001
Table 2. Distribution of predicted proportions of vision status by age group and gender in persons with trichiasis in Mankien
district (n=319).
Age Group (years) Vision Status** (%)
Males Females
Normal Vision Low Vision Blindness Normal Vision Low Vision Blindness
0–4* 100.0 0 0 100.0 0 0
5–9 94.6 5.0 0.4 96.3 3.3 0.3
10–14 90.1 9.2 0.7 93.1 6.2 0.7
15–19 83.9 14.8 1.3 88.4 10.4 1.2
20–24 76.1 21.8 2.1 82.2 15.8 2.0
25–29 67.2 29.7 3.2 74.7 22.3 3.0
30–34 57.6 37.7 4.7 66.0 29.4 4.5
35–39 48.2 45.1 6.7 56.9 36.6 6.5
40–44 39.4 51.3 9.3 47.9 43.0 9.1
45–49 31.7 55.7 12.6 39.4 48.2 12.4
50–54 25.2 58.2 16.5 32.0 51.6 16.4
55–59 19.9 58.9 21.2 25.6 53.3 21.1
60–64 15.6 57.9 26.5 20.3 53.1 26.6
65–69 12.2 55.4 32.4 16.0 51.4 32.5
70–74 9.6 51.8 38.6 12.6 48.4 38.9
75+ 7.5 47.4 45.0 10.0 44.6 45.5
*Children aged 0–4 years assumed to have normal vision.
**Vision status: Normal vision=presenting visual acuity of $6/18 in the better eye; Low vision=presenting visual acuity of ,6/18 to #3/60 in the better eye;
Blindness=presenting visual acuity of ,3/60 in the better eye.
doi:10.1371/journal.pntd.0000396.t002
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trichiasis and breakdown of prevalence of trichiasis vision status.
The prevalence of TT increased with age and females were more
likely to have TT compared to males, age adjusted Odds Ratio
(OR)=1.5 (95% CI=1.3–1.7). Consistent with prevalence of
trichiasis, prevalence of visual impairment (low vision and
blindness) increased with age (Table 3).
Life Table Characteristics for Sudan
In the 2001 Sudan life table, women had a higher life
expectancy at birth than men. The life expectancy at birth for
Sudan was 58.1 years for females and 54.1 years for males. Life
expectancy increased in age 5–9 years compared to life expectancy
at birth (age 0–4 years) to 56.8 years in males and 60.7 for females;
indicating the high under-five mortality rate.
Trichiasis Health Expectancies
Table 4, Figure 2 and Figure 3 show the life expectancy (LE)
and proportions of total life expectancy, trichiasis free life
expectancy (TTFLE), trichiasis life expectancy (TTLE), and
TTLE with normal vision, TTLE with low vision, and TTLE
with blindness. Females had a greater life expectancy at all ages
(Figure 2) than males and a larger proportion of remaining life
spent with trichiasis low vision or blindness (Figure 3). At age
five, TTFLE was 49.8 years (88% of remaining life) and 49.8
years (82% of remaining life) in males and females, respectively.
Males expected to live 7.0 (95%CI=6.2–7.8) years (12% [95%
CI=11–14] of remaining life) with trichiasis at age five; of
which 1.9 years (3% of remaining life), 3.5 years (6% of
remaining life) and 1.6 years (3% of remaining life) would be
lived with normal vision, low vision and blindness, respectively.
At age five, females TTLE was 10.9 (95%CI=9.9–11.9) years
(18% [95% CI=16–20] of remaining life) of which trichiasis
with normal vision, low vision and blindness comprised 3.3
years (6%), 4.9 years (8%) and 2.7 years (4%), respectively. For
both genders, the proportion of life spent with trichiasis
increased with age (Figure 3), by age 50 years, TTLE was
30% (6.4 years) for males and 40% (9.5 years) for females. The
proportion of remaining life with trachoma visual impairment
(low vision or blindness) at age 50 was 26% (5.5 years) for
males and 33% (7.7 years) for females.
Discussion
This study presents the application of health expectancies in
describing the burden due to trachoma by dividing life expectancy
into life spent without trichiasis and with trichiasis (trichiasis with
normal vision, trichiasis with low vision and trichiasis with
blindness). The methods can be applied to other trachoma
endemic setting, and presents a technique of estimating the burden
associated with uncontrolled trachoma. In Southern Sudan, life
expectancy at birth for the year 2001 was 54.2 for men and 58.1
years for women. At age five years, men expected to live an eighth
of remaining life with trichiasis and nearly a tenth of remaining life
with visual impairment (low vision or blindness) due to trachoma.
For women this rose to nearly a fifth of remaining life at age five
with trichiasis and an eighth of remaining life with trachomatous
visual impairment. Not only were women estimated to live longer,
they were also expected to spend a greater amount of time with
trichiasis, trichiasis with low vision, and trichiasis with blindness
compared to men.
Health expectancy is a measure that combines information on
both mortality and morbidity to derive lengths of time spent in
different states of health. The Sullivan method for calculating
health expectancies has advantages over previous summary
measures of trachoma burden because it is presented in units of
expected years of life with or without the disease condition. This is
intuitively meaningful for policy makers and a non-technical
audience, and compares favourably with other indicators such as
mortality and incidence rates or disability adjusted life years
(DALYs), which are not generally easily understood [24]. Other
advantages of the method include simplicity and relative accuracy
in addition to using data which are commonly available:
prevalence data from surveys and life tables.
In common with other countries for which vital registration is
not well established, the WHO life tables are the most
authoritative for Southern Sudan. Until recently (April 2008), no
population census has been undertaken for many years due to the
civil war, and without any vital registration we acknowledge that
the true picture for life expectancy in Southern Sudan is difficult to
ascertain and may differ from the WHO estimates. Indeed, data
collected during the war suggest a total life expectancy for both
males and females of just 42 years [25]. However, the Modified
Logit model life tables used by WHO were developed in order to
address systematic deviations in mortality patterns observed as
levels of child and adult mortality deviate from the standard, and
this method has been used extensively by WHO to produce life
tables for countries with poor vital registration [21].
Our study has a number of potential limitations. The random
walk method, whilst acceptable for other purposes is not ideal
where the outcome being assessed is one that is obvious to those
involved in guiding the survey teams. Bias could have been
introduced since the village guides may have been more likely to
direct the survey teams to households where they knew there were
persons with TT or visual impairment [26]. The Sullivan health
expectancies are not appropriate for modelling dynamic changes
associated with disease control interventions since it takes a long
time for the age specific prevalence of a disability to reach the
equilibrium values corresponding to the changes in age specific
incidence rates [27]. In addition, cross-sectional data incorporate
past recovery, incidence and death rates in the prevalence at
particular ages; hence the effects of these rates on health
expectancy are more difficult to disentangle [28]. Two other
methods are used for calculating health expectancies: multiple-
decrement life tables [29] and increment-decrement or multi-state
life tables [30]. These methods employ longitudinal data and
provide more robust basis for predicting service needs and may be
useful in estimating the effects of trachoma control interventions,
for instance, eyelid surgery for TT. However, unlike the Sullivan
method, these later methods are less used due to lack of
appropriate longitudinal data.
Data on distribution of vision status among persons with TT was
only available for one district and these were applied to the
population prevalence of TT calculated from a large sample from 11
districts, rather than modelling data for each district separately.
However, a potential limitation with our VA models is that the
effects of co-morbidity of other conditions leading to visual
impairment such as refractive error were not controlled for in our
model for distribution of VA [19]. Overall, there will be some people
for whom this approach is likely to have resulted in an overestimate
of trichiasis life expectancy. For others, this approach could have
underestimated trichiasis life expectancy, since trachoma may have
been causing a proportion of their vision loss, even if not the main
cause of vision loss. The effects of co-morbidity thus operate in both
directions and the overall bias in estimated potential gain in health
expectancy is likely to be very small [31].
Consistent with other studies, our study showed longer life
expectancy and trichiasis free life expectancy in females compared
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www.plosntds.org 7 March 2009 | Volume 3 | Issue 3 | e396Figure 2. Trichiasis free life expectancy (TTFLE), Trichiasis life expectancy (TTLE) with normal vision, TTLE with low vision and TTLE
with blindness by gender. Normal vision=presenting visual acuity of $6/18 in the better eye; Low vision=presenting visual acuity of ,6/18 to
$3/60 in the better eye; Blindness=presenting visual acuity of ,3/60 in the better eye.
doi:10.1371/journal.pntd.0000396.g002
Figure 3. Proportion of life expectancy: without trichiasis; with trichiasis and with normal vision; with trichiasis and low vision; and
with trichiasis and blindness by gender. Normal vision=presenting visual acuity of $6/18 in the better eye; Low vision=presenting visual
acuity of ,6/18 to $3/60 in the better eye; Blindness=presenting visual acuity of ,3/60 in the better eye.
doi:10.1371/journal.pntd.0000396.g003
Health Expectancies for Blinding Trachoma
www.plosntds.org 8 March 2009 | Volume 3 | Issue 3 | e396to males. In addition, females experienced greater proportions of
years lived with trichiasis. Generally, the greater proportion of
years lived with disability in females has been suggested to be as a
result of longer overall survival or longer survival after the
development of disability or disease [32]. Survey data from most
trachoma endemic countries have consistently found the preva-
lence of scarring, trichiasis, and trachoma related blindness to be
higher in females compared to males [33]. Therefore, the female
excess in low vision or blindness associated with trichiasis is
consistent with both greater survival and greater risk of
trachomatous blindness among females.
Conclusion
We have presented the burden of trachomatous vision loss by
age and gender using health expectancies. These data are of value
in advocacy for trachoma control in engagement with politicians
and donors. Unless action is taken by further delivery of trachoma
control interventions, then populations in Southern Sudan can
expect to spend a substantial proportion of their life with low
vision or blindness due to trachoma.
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